After 28-day continuous treatment with the LS extract (1000 mg/kg) and glibenclamide (5 mg/kg) in STZ-NA-induced DM mice, GLUT4 expression level was significantly enhanced as compared with that of untreated-STZ-NA-induced DM mice (p < 0.05). Here, SLC2A4 is linked to diabetes mellitus.